Navigation Links
Dian Donnai receives lifetime award in genetics from March of Dimes
Date:3/26/2010

ALBUQUERQUE, N.M., MARCH 26, 2010 A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.

Dian Donnai, a professor of medical genetics at the University of Manchester and the current President of the European Society for Human Genetics, is known for her research on rare genetic diseases, such as Williams syndrome, in which individuals have heart defects and cognitive disabilities.

"We are proud to recognize Prof. Donnai's research career and her commitment to making genetic services and counseling available to all," said Dr. Michael Katz, senior vice president for Research and Global Programs at the March of Dimes. "Not only has her work helped improve the lives of those affected by rare genetic diseases, but it also has benefited millions of others seeking information and support."

Dr. Katz presented the award to Prof. Donnai today at the Annual Clinical Genetics Meeting of the American College of Medical Genetics, held at the Albuquerque Convention Center.

Professor Donnai is the clinical head of St. Mary's Hospital in the Central Manchester University Hospitals NHS Trust which includes the Genetic Medicine Center. The center serves more than five million people and offers a host of diagnostic, counseling and support services as well as an extensive research program. It is one of the largest and most comprehensive genetics centers in Europe.

Professor Donnai also is executive director of Nowgen, a center originally funded in 2002 by the United Kingdom Departments of Health and Trade & Industry to improve the practice of genetic medicine. She has long been an advocate for more dialogue among patients, the public and the genetic healthcare community Many of Nowgen's initiatives, such as encouraging patient empowerment to studying the economic impact of genetic medicine on the healthcare system, reflect this.

In addition to her research into the causes of Williams syndrome, Professor Donnai also has identified a specific mutation that became known as Donnai-Barrow syndrome, named for her and one of her colleagues. Donnai-Barrow syndrome now is considered part of a group of syndromes characterized by severe functional deficiencies, including severe hearing and vision loss, learning disabilities, as well as internal problems.

Professor Donnai qualified in medicine in London and then trained in pediatrics and genetics in London, Sheffield and Manchester. She is a fellow of the Academy of Medical Services and past president of the Medical Sciences Section of the British Association for the Advancement of Science. She was the consultant advisor to the Chief Medical Officer for England from 1998 to 2004 and was appointed Commander of the Order of British Empire in 2005.

The March of Dimes/Colonel Harland Sanders Award for Lifetime Achievement in the field of genetic sciences is given annually to an individual who has made a significant contribution to the genetic sciences.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Related biology news :

1. WPI receives $1.4 million from NIH for pioneering work on arterial plaque and cardiovascular disease
2. Lombardi receives $7.5 million grant for Breast Cancer Center for Cancer Systems Biology
3. WPI receives $1.2 million NIST award for pioneering study of wireless body area networks
4. Springer editorial board member receives Humboldt Research Award
5. Clemson researcher receives grant to study engineering enrollment of women, minorities
6. NJIT electrical engineer Yanchao Zhang receives NSF CAREER Award
7. Dr. Harmit Malik receives Vilcek Prize for creative promise in biomedical science
8. Oberthur Technologies Receives Product Innovation Award
9. Caltech receives more than $33 million from American Recovery and Reinvestment Act
10. Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever
11. Carnegie Mellons John Kitchin receives early career award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):
(Date:9/22/2017)... ... September 22, 2017 , ... ... is now being assessed in clinical trials in the United States. (clinicaltrials.gov : ... your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ ...
(Date:9/21/2017)... , ... September 21, 2017 , ... Dr. Greg Leyer, ... Vegas, NV on September 27th. His presentation is at 12:10pm in the Probiotics Resource ... to present at SupplySide West and discuss how probiotics have shown impressive data in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Colpitts Clinical has launched the ... includes new features that facilitate streamlined and compliant communication, file sharing and document ... forefront of medical advancements, they rely on efficiencies to help them address the ...
(Date:9/21/2017)... New Jersey (PRWEB) , ... September 21, 2017 ... ... highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 ... Part 11 training - Compliance with Regulation 21 CFR Part 11 on ...
Breaking Biology Technology: